Regeneron's Bispecific Cancer Treatment Faces Another Setback; Allogene Reveals Death in Clinical Trial

Regeneron’s Bispecific Cancer Treatment Faces Another Setback; Allogene Reveals Death in Clinical Trial

Regeneron's Bispecific Cancer Treatment Faces Another Setback; Allogene Reveals Death in Clinical Trial